JIM TALIAFERRO COMM MENTAL HLTH CNTR
1. Target Overview & Investment Thesis
JIM TALIAFERRO COMM MENTAL HLTH CNTR is a 14-bed safety-net/medicaid heavy in COMANCHE, OK with $4.5M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 5.4% Medicare, 62.6% Medicaid, and 32.1% commercial.
Thesis: Turnaround. Our ML models identify $344K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -243.4% (+764bps).
| Net Revenue HCRIS | $4.5M |
| Current EBITDA COMPUTED | $-11.3M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 91.4% |
| Revenue / Bed COMPUTED | $321K |
| Net-to-Gross HCRIS | 20.2% |
| Distress Probability ML | 52.1% |
2. Market Context & Competitive Position
OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -100.0% places it below the state median. Among 53 size-comparable peers (7-28 beds), the median margin is -17.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (7-28), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| JIM TALIAFERRO COMM MENTAL HLT (Target) | OK | 14 | $4.5M | -100.0% |
| OKLAHOMA SPINE HOSPITAL | OK | 23 | $79.0M | 8.4% |
| BRISTOW MEDICAL CENTER | OK | 25 | $48.5M | -12.6% |
| JEFFERSON COUNTY HOSPITAL | OK | 25 | $41.1M | 14.4% |
| PHYSICIANS HOSPITAL AT ANADARK | OK | 25 | $34.1M | -48.1% |
| LAKESIDE WOMENS HOSPITAL | OK | 23 | $33.0M | 16.5% |
| STROUD REGIONAL MEDICAL CENTER | OK | 25 | $31.4M | -50.0% |
| SURGICAL HOSPITAL OF OKLAHOMA | OK | 12 | $31.2M | -13.0% |
| HILLCREST HOSPITAL PRYOR | OK | 21 | $30.6M | -7.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $344K (764bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Denial Rate Reduction | 12.0% | 6.5% | $95K | +211bp | 12mo |
| Net Collection Rate | 93.5% | 97.0% | $94K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $90K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $55K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +21bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-11.3M |
| + RCM Uplift | +$344K |
| Pro Forma EBITDA | $-10.9M |
| Current Margin | -100.0% |
| Pro Forma Margin | -243.4% |
| WC Released (1x) | $173K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-17.4M | $-71.0M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-17.4M | $-83.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-15.6M | $-88.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-15.6M | $-100.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-19.1M | $-67.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-19.1M | $-80.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (62.6%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 52.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 7-28 beds
- Same-state prioritization (n=58)
- Comp margins: P25=-32.3% / P50=-17.6% / P75=-5.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.